It was concluded that the deletion of CARD9 might afford protection against metabolic dysfunction associated with diet-induced obesity, presumably mediated via the CARD9-MAPK signaling axis. The gene discussed is CARD9; the disease is obesity due to melanocortin 4 receptor deficiency.